TZDs, GLP-1 agonist may worsen diabetic retinal disease

Two classes of drugs commonly used to treat type 2 diabetes and theoretically prevent its complications may instead be associated with progression of diabetic retinal disease, said investigators in two studies presented here.

Related Videos
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Beth Lown, MD
© 2023 MJH Life Sciences

All rights reserved.